Ex Vivo T Cell Cytokine Expression Predicts Survival in Patients with Severe Alcoholic Hepatitis
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Alcoholic hepatitis (AH) is an acute inflammatory liver condition with high early mortality rate. Steroids improve short-term survival but nonresponders have the worst outcomes. There is a clinical need to identify these high-risk individuals at the time of presentation. T cells are implicated in AH and steroid responsiveness. We measured ex vivo T cell cytokine expression as a candidate biomarker of outcomes in patients with AH. Consecutive patients (bilirubin >80 μmol/L and ratio of aspartate aminotransferase to alanine aminotransferase >1.5 who were heavy alcohol consumers with discriminant function [DF] ≥32), were recruited from University Hospitals Plymouth NHS Trust. T cells were obtained and stimulated ex vivo. Cytokine expression levels were determined by flow cytometry and protein multiplex analysis. Twenty-three patients were recruited (10 male; median age 51 years; baseline DF 67; 30% 90-day mortality). Compared to T cells from nonsurvivors at day 90, T cells from survivors had higher baseline baseline intracellular interleukin (IL)-10:IL-17A ratio (0.43 vs 1.20, p=0.02). Multiplex protein analysis identified interferon γ (IFNγ) and tumor necrosis factor-α (TNF-α) as independent predictors of 90-day mortality (p=0.04, p=0.01, respectively). The ratio of IFNγ to TNF-α was predictive of 90-day mortality (1.4 vs 0.2, p=0.03). These data demonstrate the potential utility of T cell cytokine release assays performed on pretreatment blood samples as biomarkers of survival in patients with severe AH. Our key findings were that intracellular IL-10:IL-17A and IFNγ:TNF-α in culture supernatants were predictors of 90-day mortality. This offers the promise of developing T cell-based diagnostic tools for risk stratification.
Abstract
Alcoholic hepatitis (AH) is an acute inflammatory liver condition with high early mortality rate. Steroids improve short-term survival but nonresponders have the worst outcomes. There is a clinical need to identify these high-risk individuals at the time of presentation. T cells are implicated in AH and steroid responsiveness. We measured ex vivo T cell cytokine expression as a candidate biomarker of outcomes in patients with AH. Consecutive patients (bilirubin >80 μmol/L and ratio of aspartate aminotransferase to alanine aminotransferase >1.5 who were heavy alcohol consumers with discriminant function [DF] ≥32), were recruited from University Hospitals Plymouth NHS Trust. T cells were obtained and stimulated ex vivo. Cytokine expression levels were determined by flow cytometry and protein multiplex analysis. Twenty-three patients were recruited (10 male; median age 51 years; baseline DF 67; 30% 90-day mortality). Compared to T cells from nonsurvivors at day 90, T cells from survivors had higher baseline baseline intracellular interleukin (IL)-10:IL-17A ratio (0.43 vs 1.20, p=0.02). Multiplex protein analysis identified interferon γ (IFNγ) and tumor necrosis factor-α (TNF-α) as independent predictors of 90-day mortality (p=0.04, p=0.01, respectively). The ratio of IFNγ to TNF-α was predictive of 90-day mortality (1.4 vs 0.2, p=0.03). These data demonstrate the potential utility of T cell cytokine release assays performed on pretreatment blood samples as biomarkers of survival in patients with severe AH. Our key findings were that intracellular IL-10:IL-17A and IFNγ:TNF-α in culture supernatants were predictors of 90-day mortality. This offers the promise of developing T cell-based diagnostic tools for risk stratification.
참고문헌 (14)
- Thursz MR, "Prednisolone or pentoxifylline for alcoholic hepatitis", N Engl J Med, 372, pp.1619~1628 (2015)
- Louvet A, "Corticosteroids reduce risk of death within 28 days for patients with severe alcoholic hepatitis, compared with pentoxifylline or placebo-a meta-analysis of individual data from controlled trials", Gastroenterology, 155, pp.458~468 (2018)
- Louvet A, "The Lille model : a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids", Hepatology, 45, pp.1348~1354 (2007)
- Dhanda AD, "Long-term outcome in patients with severe alcoholic hepatitis can be reliably determined using an in vitro measure of steroid sensitivity", Hepatology, 61, pp.1099~ (2015)
- di Mambro AJ, "In vitro steroid resistance correlates with outcome in severe alcoholic hepatitis", Hepatology, 53, pp.1316~1322 (2011)
- Diel R, "Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection : a systematic review and meta-analysis", Eur Respir J, 37, pp.88~99 (2011)
- Lee RW, "Steroid refractory CD4+ T cells in patients with sight-threatening uveitis", Invest Ophthalmol Vis Sci, 50, pp.4273~4278 (2009)
- Mookerjee RP, "Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts the outcome", Hepatology, 46, pp.831~840 (2007)
- Vergis N, "Defective monocyte oxidative burst predicts infection in alcoholic hepatitis and is associated with reduced expression of NADPH oxidase", Gut, 66, pp.519~529 (2017)
- Dhanda AD, "Immune dysfunction in acute alcoholic hepatitis", World J Gastroenterol, 21, pp.11904~11913 (2015)
- Affò S, "Transcriptome analysis identifies TNF superfamily receptors as potential therapeutic targets in alcoholic hepatitis", Gut, 62, pp.452~460 (2013)
- Affò S, "CCL20 mediates lipopolysaccharide induced liver injury and is a potential driver of inflammation and fibrosis in alcoholic hepatitis", Gut, 63, pp.1782~1792 (2014)
- Lemmers A, "The interleukin-17 pathway is involved in human alcoholic liver disease", Hepatology, 49, pp.646~657 (2009)
- Markwick LJ, "Blockade of PD1 and TIM3 restores innate and adaptive immunity in patients with acute alcoholic hepatitis", Gastroenterology, 148, pp.590~602 (2015)